Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun:68:49-56.
doi: 10.1016/j.gde.2021.01.011. Epub 2021 Mar 2.

16p11.2 deletion syndrome

Affiliations
Review

16p11.2 deletion syndrome

Wendy K Chung et al. Curr Opin Genet Dev. 2021 Jun.

Abstract

The 16p11.2 BP4 and BP5 region, is a recurrent ∼600kb copy number variant (CNV), and deletions are one of the most frequent etiologies of neurodevelopmental disorders and autism spectrum disorder with an incidence of approximately 1/2000. Deletion carriers have delays in early neurodevelopment that most specifically impair speech, phonology and language in 70%. Intelligence quotient is shifted 1.8 standard deviations lower than family controls without the deletion. Other common neurobehavioral conditions include motor coordination difficulties (60%) and autism (20-25%). Unprovoked seizures are common (24%) and readily treated and resolve with age in many. Obesity evolves throughout childhood and by adulthood 75% are obese. Congenital anomalies are more common than the general population. The deletion is associated with an increase in brain volumes across all areas of the brain, changes in the white matter microstructural properties, and early electrophysiological cortical responses from auditory cortex. Studies of genetically defined conditions, particularly CNVs that are not associated with profound disabilities, provide homogeneity to study genetic impact on brain development, structure, and function to better understand complex neurobehavioral phenotypes such as autism.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement

TR declares equity positions in Prism Clinical Imaging and Proteus Neurodynamics. He also declares consulting/advisory board relationships with CTF, Ricoh, Spago Nanomedicine, Avexis and Acadia Pharmaceuticals.

LGS and JES are employees of the Simons Foundation.

Figures

Figure 1
Figure 1
The gene content of the BP4-BP5 region of 16p11.2 with genes of interest potentially responsible for portions of the phenotype highlighted in red.
Figure 2
Figure 2
(a) Anthropometric measures of 16p11.2 carriers over time. Body mass index (BMI) increases over childhood, and head circumference increases over the first two years of age. (b) Brain volume as determined by brain MRI of 16p11.2 deletion carriers (DEL) relative to controls (CON) and duplication carriers (DUP) compared to controls (CON) shows relatively larger brain volumes in deletion carriers and smaller brain volumes in duplication carriers [29].
Figure 3
Figure 3
Diagnostic behavioral profile of 16p11.2 deletion carriers. Most individuals have more than one diagnosis.
Figure 4
Figure 4
(a) 16p11.2 deletion carriers have full scale intelligence quotient (FSIQ) of 1.8 standard deviations lower than their non-carrier siblings and parents [18]. (b) 16p11.2 deletion carriers have social responsiveness scale score of 1.7 standard deviations higher (worse) than their non-carrier siblings [18].

References

    1. Mannik K, Magi R, Mace A, Cole B, Guyatt AL, Shihab HA, Maillard AM, Alavere H, Kolk A, Reigo A et al.: Copy number variations and cognitive phenotypes in unselected populations. JAMA 2015, 313:2044–2054. - PMC - PubMed
    1. Walsh KM, Bracken MB: Copy number variation in the dosage-sensitive 16p11.2 interval accounts for only a small proportion of autism incidence: a systematic review and meta-analysis. Genet Med 2011, 13:377–384. - PubMed
    1. Kumar RA, KaraMohamed S, Sudi J, Conrad DF, Brune C, Badner JA, Gilliam TC, Nowak NJ, Cook EH Jr, Dobyns WB, Christian SL: Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet 2008, 17:628–638. - PubMed
    1. Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J, Shago M, Moessner R, Pinto D, Ren Y et al.: Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008, 82:477–488. - PMC - PubMed
    1. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, Yamrom B, Yoon S, Krasnitz A, Kendall J et al.: Strong association of de novo copy number mutations with autism. Science 2007, 316:445–449. - PMC - PubMed

Supplementary concepts